[PDF][PDF] The use of FDG-PET in the detection and management of malignant lymphoma: correlation of uptake with prognosis

J Okada, K Yoshikawa, K Imazeki… - Journal of Nuclear …, 1991 - Soc Nuclear Med
RESULTS Mean values of tumor sizes, TCRs, and OURs were shown in Table 2, and the
relationship between tumor size and TCR on PET images is shown in Figure 2. TCRs of all …

FDG-PET for predicting the prognosis of malignant lymphoma

J Okada, H Oonishi, K Yoshikawa, J Itami… - Annals of Nuclear …, 1994 - Springer
To evaluate the usefulness of FDG-PET as a predictor of prognosis, 34 patients with
untreated malignant lymphoma in the head and neck region were studied. After FDG-PET …

Positron emission tomography with 18F-FDG to detect residual disease after therapy for malignant lymphoma

U Cremerius, U Fabry, J Neuerburg… - Nuclear medicine …, 1998 - journals.lww.com
We retrospectively evaluated the use of 18 F-FDG PET for assessment of residual disease in
27 patients after therapy for malignant lymphoma. The images were evaluated qualitatively …

Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT.

JS Newman, IR Francis, MS Kaminski, RL Wahl - Radiology, 1994 - pubs.rsna.org
PURPOSE: To prospectively compare the accuracy of positron emission tomography (PET)
with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose (FDG) in imaging thoracicoabdominal …

Lymphoma: role of whole-body 2-deoxy-2-[F-18] fluoro-D-glucose (FDG) PET in nodal staging.

F Moog, M Bangerter, CG Diederichs, A Guhlmann… - Radiology, 1997 - pubs.rsna.org
PURPOSE: To compare 2-deoxy-2-[fluorine-18] fluoro-D-glucose (FDG) positron emission
tomography (PET) with computed tomography (CT) in primary nodal staging of malignant …

Potential pitfalls of 18F-FDG PET in a large series of patients treated for malignant lymphoma: prevalence and scan interpretation

P Castellucci, C Nanni, M Farsad, L Alinari… - Nuclear medicine …, 2005 - journals.lww.com
Objective To evaluate the prevalence and scan interpretation criteria useful in identifying
non-tumoural 18 F-FDG focal uptakes (potential pitfalls) in patients who had been previously …

PET/CT in lymphoma: prospective study of enhanced full-dose PET/CT versus unenhanced low-dose PET/CT

B Rodríguez-Vigil, N Gómez-León, I Pinilla… - Journal of Nuclear …, 2006 - Soc Nuclear Med
PET/CT combines functional and morphologic data and increases diagnostic accuracy in a
variety of malignancies. This study prospectively compares the agreement between contrast …

18F-FDG PET in malignant lymphoma: significance of positive findings

P Castellucci, PL Zinzani, M Pourdehnad… - European journal of …, 2005 - Springer
Purpose The aim of this study was to evaluate the significance of increased uptake of 18 F-
fluorodeoxyglucose (FDG) in patients with malignant lymphoma (ML) studied by positron …

Impact of FDG-PET/CT in the management of lymphoma

S Baba, K Abe, T Isoda, Y Maruoka, M Sasaki… - Annals of nuclear …, 2011 - Springer
Since the introduction of 67 Gallium-citrate 30 years ago, nuclear medicine has played an
important role in the evaluation of malignant lymphoma. During that time, several …

FDG PET in the evaluation of treatment for lymphoma: clinical usefulness and pitfalls

T Kazama, SC Faria, V Varavithya, S Phongkitkarun… - Radiographics, 2005 - pubs.rsna.org
Positron emission tomography (PET) with 2-[fluorine-18] fluoro-2-deoxy-d-glucose (FDG)
may play an important role in the evaluation and management of malignant lymphoma. FDG …